CD274 and Hepatic fibrosis: In CCL4-induced liver fibrosis in mice, kinsenoside can inhibit the activation and maturation of DCs by targeting the PI3K/AKT/FoxO1 signaling pathway and upregulating the expression of PD-L1 in DCs while inhibiting the release of IL-12 (177).